• Other
  • Exited

ForteBio, Inc. develops analytical systems that enable real-time analysis of biomolecular interactions (protein quantification and characterization of protein-protein interactions) in micro-volume sample sizes, providing information on affinity, kinetics, and concentration. Its systems accelerate and enhance drug discovery research at leading biopharmaceutical companies and academic institutions worldwide. ForteBio was acquired by Pall Corp. in March 2012.